-
Investors led by former CEO offer $3.9B for plasma producer China Biologic
fiercepharma
August 23, 2018
Nasdaq-listed China Biologic Products received its second buyout offer in less than three months. (Nasdaq)
-
Robert Wicke appointed as new CEO of Halo Labs
biospectrumasia
August 06, 2018
Robert Wicke succeeds Dr. Robert Hart who is transitioning to Chief Technology Officer where he will focus on innovative new products.
-
PredictImmune names Paul Kinnon as CEO
fiercebiotech
July 09, 2018
PredictImmune has named Paul Kinnon as its CEO. Kinnon, a former Life Technologies VP, has spent most of the past decade running diagnostic businesses Transgenomic and ZyGEM.
-
Novartis spins off Alcon as CEO focuses drug search
pharmafile
July 06, 2018
Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.
-
AXM Pharma appoints new
biospectrumasia
July 05, 2018
AXM Pharma is pleased to announce that its Chairman, Mr. Emmanuel Neossi, has appointed Linda L. Forster as the new Chief Executive Officer effective immediately.
-
Galectin announces new CEO
biospectrumasia
June 14, 2018
Prior to his work at Galectin, Dr. Shlevin served Georgia Institute of Technology’s Advanced Technology Development Center as manager of bioscience partnering and commercialization efforts.
-
Old CEO, new chairman? Some Allergan investors want Pyott to come back: report
fiercepharma
June 13, 2018
Last week, vocal investors called for Allergan CEO and Chairman Brent Saunders to give up one of those titles, making room for an outsider at the top. But sources said the outsider some shareholders have in mind is actually a former insider.
-
C4 Therapeutics promotes chief science officer to CEO
fiercebiotech
May 04, 2018
Andrew Phillips was named CEO of C4 Therapeutics, a 2016 Fierce 15 winner. Phillips has helped lead the Dana-Farber spinout’s research efforts...
-
Mundipharma CEO maintains position in the Power List
biospectrumasia
April 23, 2018
This is the fourth year in succession that Singh has featured among the Power List’s top business leaders.
-
Flagship cancer startup Torque gets $25M, Rhythm founder as CEO
fiercebiotech
November 15, 2017
Flagship Pioneering has launched its latest biotech, Torque, as it hopes to power through using a new class of “deep-primed” immune cell therapies in cancer.